Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha Shah, Kunal G. Maheshwari, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3847-3884
Closed Access | Times Cited: 16

Showing 16 citing articles:

Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits
Raj Katariya, Shivkumar S. Sammeta, Mayur B. Kale, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102269-102269
Closed Access | Times Cited: 7
The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs
Yamin Zhang, Yanqin Sun, Xiaojuan Hu, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 5
Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
Andreea-Daniela Meca, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarţău, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5929-5949
Open Access | Times Cited: 4
Integration of Phytochemical Profiling and Computational Approaches to Evaluate the Neuroprotective Potential of Nardostachys jatamansi in Alzheimer's Disease
Abdul Jalil Shah, Mohammad Younis Dar, Mohd Adnan, et al.
Biotechnology Reports (2025) Vol. 45, pp. e00881-e00881
Open Access
Targeting amyloidogenic proteins through cyclic peptides – A medicinal chemistry perspective
Muhammad Kazim Zargaham, Ahsan Ibrahim, Madiha Ahmed, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 123, pp. 118165-118165
Closed Access
Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer’s Disease
Francesca Gelfo, Laura Petrosini, Laura Mandolesi, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1181-1197
Closed Access | Times Cited: 3
Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer’s disease
Mengqi Hao, Jianjian Chu, Tinglin Zhang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 2, pp. 424-439
Open Access | Times Cited: 1
From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies
Mădălina Georgeta Sighencea, R. Popescu, Simona Trifu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12311-12311
Open Access | Times Cited: 1
Recent Progresses in Signal Processing for Alzheimer's Disease Detection
Mengyao Zhao
(2023)
Open Access | Times Cited: 2
Alzheimer's detection by Artificial Bee Colony and Convolutional Neural Network at Mobile Environment
Dan Shan, Fanfeng Shi, Tianzhi Le
Mobile Networks and Applications (2024)
Closed Access
Exploring the Potential of Bioactive Compounds as Interventions for Dementia: Current Insights and Future Directions
Nicholas-Okpara Viola A.N., Maryam Olanshile Adegboyega, Julius Enyong Oben, et al.
Functional Food Science - Online ISSN 2767-3146 (2024) Vol. 4, Iss. 5, pp. 166-179
Open Access
Metformin Carbon Dots Enhance Neurogenesis and Neuroprotection in Alzheimer's Disease: A Potential Nanomedicine Approach
Jing Zhang, Xuehan Yang, Sushan Wang, et al.
Materials Today Bio (2024) Vol. 29, pp. 101347-101347
Open Access
Abordagens Terapêuticas no Tratamento da Doença de Alzheimer: uma revisão abrangente
Marco Aurélio Libório Sinhorini Fonseca, Breno Luiz Henriques Amaral, Bruce Ferreira da Costa, et al.
Brazilian Journal of Implantology and Health Sciences (2023) Vol. 5, Iss. 5, pp. 3239-3250
Open Access | Times Cited: 1
Research Progress in the Treatment of Alzheimer’s Disease Based on Microbiota-Gut-Brain Axis
蝶 张
Advances in Clinical Medicine (2023) Vol. 13, Iss. 12, pp. 20380-20385
Closed Access
Page 1

Scroll to top